Oracle has debuted its Healthcare Precision Medicine software, doubling its efforts in an area that may be the next revolution in drug development and healthcare.

Healthcare Precision Medicine is designed to connect genetic testing, report generation and clinical care decision-making, the database and enterprise application giant said. The new software supports a shift in clinical research and healthcare from a one-size-fits-all approach of combating disease to precision medicine, a method that treats biological variations of individual patients.

Oracle Healthcare Precision Medicine addresses data aggregation, knowledge exchange, normalization and workflow issues that restrict timely creation of patient molecular profiles, Oracle said.

[Also: SAP, Oracle look beyond 'artisanal' practice]

According to Oracle, the new software also facilitates spectrum testing from gene panels through whole genome sequencing, test throughput via streamlined lab workflow, consistent report design and simplified clinical action planning, traceability for compliance requirements, and  integration with electronic health record systems and systems from other vendors for seamless clinical workflow and adoption.

Oracle has supported precision medicine efforts for about 6 years, the company said. Rivals including SAP and Microsoft have also been ramping up efforts in the realm, with SAP in early December announcing Foundation for Health and Medical Research Insights with a bent toward clinical research and improving outcomes.

Last year at HIMSS15, in fact, both Oracle and SAP touted precision medicine tools with a focus on moving beyond so-called artisanal medicine, wherein clinicians and physicians make care decision based on limited data sets because that is the best information they have to work with.

[Also: SAP precision medicine software aims to improve research]

President Barack Obama has described precision medicine as “one of the greatest opportunities for new medical breakthroughs ever seen.” For example, with precision medicine treatments, survival rates for colorectal cancer have increased by 15 percent and hospitalization for heart patients has declined by 30 percent, according to the 2015 annual report of The Personalized Medicine Coalition.

Twitter: @SiwickiHealthIT